Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
c-MET pathway acts on several downstream effectors including phospholipase C gamma (PLC), cellular Src kinase (c-Src), phosphotidylinsitol-3-OH kinase (PI3K), alpha serine/threonine-protein kinase (Akt), mitogen-activated protein kinase (MAPK), and wingless-related integration site (Wnt) pathways
Reconstitution calculator Work out your exact units per dose, never in mL
Be cautious when medical necessity is secondary to memberships, prepaid bundles, standard cocktails, or promises of energy and immunity
Patients and providers should treat them as directional rather than definitive, and decisions about participating in trials or accessing investigational therapies should always involve a specialist in endocrinology or metabolic medicine.
Safety Considerations and Side Effects Whilst GLP-1 receptor agonists demonstrate good overall tolerability, patients and prescribers must understand potential adverse effects and safety considerations, particularly for menopausal women who may have age-related comorbidities
